Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

LASA SUPERGENERICS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) -9.50-36.946.368.51-3,684.39

What is the latest Working Capital/Sales ratio of LASA SUPERGENERICS ?

The latest Working Capital/Sales ratio of LASA SUPERGENERICS is -9.50 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar2024-9.50
Mar2023-36.94
Mar20226.36
Mar20218.51
Mar2020-3,684.39

How is Working Capital/Sales of LASA SUPERGENERICS Trending?

Years Working Capital/Sales % Change
Mar2024 -9.5
Negative
Mar2023 -36.94
Negative
Mar2022 6.36
-25.26
Mar2021 8.51
Positive
Mar2020 -3684.39 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Working Capital/Sales ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹31.3 Cr -3.1% -22.7% -67.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-3.1%

-22.7%

-67.8%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses